HYALGAN 20 mg/2 ml, solution for injection for intra-articular use in a pre-filled syringe syringe, 2 ml
Active ingredients: Hyaluronan sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 2 mlintraarticulaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HYALGAN 20 mg/2 ml, solution injectable pour voie intra-articulaire en seringue pré-remplie
- Pharmaceutical form
- solution injectable
- Route of administration
- intraarticulaire
- Presentation description
- 1 seringue(s) pré-remplie(s) en verre de 2 ml
- Marketing authorisation holder
- FIDIA FARMACEUTICI S.P.A. (ITALIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Jan 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64052038CIP73356571CIP133400933565718Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SODIUM (HYALURONATE DE)solution | 20 mg · une seringue | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.